PMID- 3754056 OWN - NLM STAT- MEDLINE DCOM- 19860411 LR - 20041117 IS - 0033-8419 (Print) IS - 0033-8419 (Linking) VI - 159 IP - 1 DP - 1986 Apr TI - Prostatic cancer therapy: comparison of external-beam radiation and I-125 seed implantation treatment of stages B and C neoplasms. PG - 249-52 AB - Of 179 patients with stage B or C adenocarcinoma of the prostate, 106 underwent iodine-125 seed-implant therapy (I-125 SI) and 73 received external-beam radiation therapy (EB). A retrospective analysis determined disease-free survival rate, local tumor control, and complication rate for each treatment group. The 5-year disease-free survival rates for SI-treated patients were 75% for stage B and 30% for stage C groups. Corresponding rates for EB-treated patients were 75% and 40%, respectively. The rate of local tumor control for stage B patients was 85% for SI-treated and 88% for EB-treated patients. The corresponding rates for stage C tumors were 75% for SI-treated and 92% for EB-treated patients. The rate of long-term complications in each group was approximately 10%. For stage B cancer of the prostate, I-125 SI treatment is an acceptable alternative to EB therapy; our data are inconclusive regarding stage C treatment, but EB therapy is preferred. FAU - Morton, J D AU - Morton JD FAU - Harrison, L B AU - Harrison LB FAU - Peschel, R E AU - Peschel RE LA - eng PT - Journal Article PL - United States TA - Radiology JT - Radiology JID - 0401260 RN - 0 (Iodine Radioisotopes) SB - IM MH - Carcinoma/mortality/*radiotherapy MH - Humans MH - Iodine Radioisotopes/*therapeutic use MH - Male MH - Prostatic Neoplasms/mortality/*radiotherapy EDAT- 1986/04/01 00:00 MHDA- 1986/04/01 00:01 CRDT- 1986/04/01 00:00 PHST- 1986/04/01 00:00 [pubmed] PHST- 1986/04/01 00:01 [medline] PHST- 1986/04/01 00:00 [entrez] AID - 10.1148/radiology.159.1.3754056 [doi] PST - ppublish SO - Radiology. 1986 Apr;159(1):249-52. doi: 10.1148/radiology.159.1.3754056.